USA: Metabolic bariatric surgery delivers greater and more durable weight loss than popular weight-loss injections while costing less over time, reports a new study in JAMA Surgery. The analysis challenges the view of bariatric surgery as a last-resort option and calls for a re-examination of current treatment pathways. The key findings of the study were as follows:Over two years, the average total costs were approximately $63,500 for GLP-1 therapy, compared with roughly $51,800 for bariatric surgery, resulting in a gap of nearly $11,700. Patients who underwent surgery lost an average of 28% of their body weight, while those on GLP-1 therapy lost approximately 10%. Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists.